Skip to content

6-KAccepted Sep 11, 5:02 PM ET

Agomab Therapeutics NV 6-K

AGMBAgomAb Therapeutics NV

sec.gov(opens the filing on sec.gov)View full filing

Accepted (ET)

5:02 PM

Sep 11, 2026

Filed

Sep 11, 2026

Documents

3

Size

29.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.